Detalhe da pesquisa
1.
Phase I/II Trial of Carboplatin, Nab-paclitaxel, and Pembrolizumab for Advanced Non-Small Cell Lung Cancer: Hoosier Cancer Research Network LUN13-175.
Oncologist
; 29(1): 47-56, 2024 Jan 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-37390616
2.
Top advances in lung cancer, 2021.
Cancer
; 128(19): 3434-3437, 2022 10 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-35947027
3.
Management of Immunotherapy-Related Toxicities, Version 1.2022, NCCN Clinical Practice Guidelines in Oncology.
J Natl Compr Canc Netw
; 20(4): 387-405, 2022 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-35390769
4.
Metastatic Thymoma Harboring a Deleterious BRCA2 Mutation Derives Durable Clinical Benefit from Olaparib.
Oncologist
; 25(4): 301-305, 2020 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-32297440
5.
NCCN Guidelines Insights: Management of Immunotherapy-Related Toxicities, Version 1.2020.
J Natl Compr Canc Netw
; 18(3): 230-241, 2020 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-32135517
6.
Management of Immunotherapy-Related Toxicities, Version 1.2019.
J Natl Compr Canc Netw
; 17(3): 255-289, 2019 03 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-30865922
7.
Intracranial Response to Anti-Programmed Death 1 Therapy in a Patient with Metastatic Non-Small Cell Lung Cancer with Leptomeningeal Carcinomatosis.
Oncologist
; 23(12): e159-e161, 2018 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-30072392
8.
Patient-centered engagement and symptom/toxicity monitoring in the new era of tumor next-generation sequencing and immunotherapy: The OncoTool and OncoPRO platforms.
Cancer
; 125(14): 2338-2344, 2019 07 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-31034599
9.
A review of eligibility for patients with central nervous system (CNS) metastases from non-small cell lung cancer (NSCLC) in immunotherapy clinical trials.
J Neurooncol
; 144(1): 235-237, 2019 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-31240523
10.
Implementing a Patient-Reported Outcome Dashboard in Oncology Telemedicine Encounters: Clinician and Patient Adoption and Acceptability.
JCO Oncol Pract
; 20(3): 409-418, 2024 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-38207229
11.
Cancer Surveillance in Solid Organ Transplant Recipients With a Pretransplant History of Malignancy: Multidisciplinary Collaborative Expert Opinion.
Transplantation
; 2024 May 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-38771067
12.
General population reference values for the Functional Assessment of Cancer Therapy-Lung and PROMIS-29.
Cancer Med
; 12(11): 12765-12776, 2023 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-37148552
13.
Regulatory T-Cells as an Emerging Barrier to Immune Checkpoint Inhibition in Lung Cancer.
Front Oncol
; 11: 684098, 2021.
Artigo
em Inglês
| MEDLINE | ID: mdl-34141625
14.
The Impact of Beta Blockers on Survival Outcomes in Patients With Non-small-cell Lung Cancer Treated With Immune Checkpoint Inhibitors.
Clin Lung Cancer
; 22(1): e57-e62, 2021 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-32900613
15.
Patient-reported tolerability of veliparib combined with cisplatin and etoposide for treatment of extensive stage small cell lung cancer: Neurotoxicity and adherence data from the ECOG ACRIN cancer research group E2511 phase II randomized trial.
Cancer Med
; 9(20): 7511-7523, 2020 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-32860331
16.
Eating patterns and overweight status in young adults: the Bogalusa Heart Study.
Int J Food Sci Nutr
; 60 Suppl 3: 14-25, 2009.
Artigo
em Inglês
| MEDLINE | ID: mdl-19462322
17.
Alveolar soft part sarcoma mimics prostate cancer metastasis.
Oxf Med Case Reports
; 2019(12): 507-509, 2019 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-31908823
18.
Preventing, Monitoring, and Managing Ototoxicity Related to Cisplatin: Proactive Rather Than Reactive Approaches Are Needed.
JCO Oncol Pract
; 19(5): 286-287, 2023 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-37018651
19.
Use of Low-Frequency Driver Mutations Detected by Cell-Free Circulating Tumor DNA to Guide Targeted Therapy in Non-Small-Cell Lung Cancer: A Multicenter Case Series.
JCO Precis Oncol
; 2: 1-10, 2018 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-35135131
20.
Biomarkers for PD-1/PD-L1 Blockade Therapy in Non-Small-cell Lung Cancer: Is PD-L1 Expression a Good Marker for Patient Selection?
Clin Lung Cancer
; 17(5): 350-361, 2016 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-27137346